| Primary |
| Hypokalaemia |
17.1% |
| Hypertension |
13.6% |
| Cardiac Disorder |
8.6% |
| Blood Potassium Decreased |
7.1% |
| Muscle Spasms |
7.1% |
| Asthma |
5.0% |
| Suicide Attempt |
5.0% |
| Cardiac Failure Congestive |
3.6% |
| Depression |
3.6% |
| Diabetes Mellitus |
3.6% |
| Diuretic Therapy |
3.6% |
| Blood Cholesterol Increased |
2.9% |
| Cardiac Failure Acute |
2.9% |
| Crohn's Disease |
2.9% |
| Gout |
2.9% |
| Myalgia |
2.9% |
| Oedema |
2.9% |
| Electrolyte Substitution Therapy |
2.1% |
| Arrhythmia |
1.4% |
| Arthritis |
1.4% |
|
| Muscle Spasms |
10.2% |
| Ventricular Tachycardia |
8.2% |
| Hepatic Function Abnormal |
6.1% |
| Renal Impairment |
6.1% |
| Retching |
6.1% |
| Vomiting |
6.1% |
| Weight Decreased |
6.1% |
| Cerebrovascular Accident |
4.1% |
| Incorrect Dose Administered |
4.1% |
| Platelet Count Decreased |
4.1% |
| Poor Quality Drug Administered |
4.1% |
| Poor Quality Sleep |
4.1% |
| Pyrexia |
4.1% |
| Rash |
4.1% |
| Renal Failure Acute |
4.1% |
| Tendonitis |
4.1% |
| Urinary Tract Infection |
4.1% |
| White Blood Cell Count Decreased |
4.1% |
| White Blood Cell Count Increased |
4.1% |
| Accidental Exposure |
2.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
17.5% |
| Hypertension |
12.5% |
| Hypokalaemia |
11.1% |
| Cardiac Failure |
10.7% |
| Prophylaxis |
8.2% |
| Cardiac Failure Chronic |
5.5% |
| Product Used For Unknown Indication |
5.0% |
| Tachyarrhythmia |
3.6% |
| Intentional Overdose |
3.2% |
| Rash |
2.7% |
| Blood Potassium Decreased |
2.5% |
| Gastritis |
2.5% |
| Osteoporosis |
2.5% |
| Osteoarthritis |
2.0% |
| Concomitant Disease Aggravated |
1.8% |
| Constipation |
1.8% |
| General Anaesthesia |
1.8% |
| Type 2 Diabetes Mellitus |
1.8% |
| Anaesthesia |
1.6% |
| Asthma |
1.6% |
|
| Suicide Attempt |
8.7% |
| Ventricular Fibrillation |
8.7% |
| Vomiting |
8.7% |
| Asthma |
7.2% |
| Pulmonary Oedema |
7.2% |
| Primary Hyperaldosteronism |
5.8% |
| Toxic Epidermal Necrolysis |
5.8% |
| Ventricular Tachycardia |
5.8% |
| Diarrhoea |
4.3% |
| Lung Abscess |
4.3% |
| Muscle Spasms |
4.3% |
| Platelet Count Decreased |
4.3% |
| Schizophrenia |
4.3% |
| Blood Potassium Decreased |
2.9% |
| Blood Pressure Decreased |
2.9% |
| Cardio-respiratory Arrest |
2.9% |
| Cerebral Infarction |
2.9% |
| Cholestasis |
2.9% |
| Gastric Ulcer Perforation |
2.9% |
| Liver Disorder |
2.9% |
|
| Concomitant |
| Drug Use For Unknown Indication |
18.8% |
| Product Used For Unknown Indication |
16.1% |
| Prophylaxis |
11.5% |
| Hypertension |
7.8% |
| Diffuse Large B-cell Lymphoma |
5.8% |
| Multiple Myeloma |
4.7% |
| Rheumatoid Arthritis |
4.6% |
| Hypokalaemia |
4.2% |
| Constipation |
3.3% |
| Adult T-cell Lymphoma/leukaemia |
2.6% |
| Diabetes Mellitus |
2.6% |
| Pain |
2.5% |
| Pulmonary Arterial Hypertension |
2.4% |
| Insomnia |
2.2% |
| Cardiac Failure |
2.1% |
| Cardiac Failure Chronic |
1.9% |
| Atrial Fibrillation |
1.8% |
| Crohn's Disease |
1.8% |
| Nausea |
1.7% |
| Sepsis |
1.7% |
|
| Vomiting |
13.8% |
| Pyrexia |
7.4% |
| White Blood Cell Count Decreased |
7.2% |
| Sepsis |
5.9% |
| White Blood Cell Count Increased |
5.4% |
| Renal Failure Acute |
5.2% |
| Pneumonia |
4.9% |
| Thrombocytopenia |
4.9% |
| Ventricular Tachycardia |
4.9% |
| Death |
4.7% |
| Rhabdomyolysis |
4.4% |
| Interstitial Lung Disease |
3.7% |
| Pulmonary Embolism |
3.7% |
| Renal Impairment |
3.7% |
| Cardiac Failure |
3.5% |
| Liver Disorder |
3.5% |
| Respiratory Failure |
3.5% |
| Septic Shock |
3.5% |
| Right Ventricular Failure |
3.2% |
| Weight Decreased |
3.0% |
|
| Interacting |
| Asthma |
33.3% |
| Electrolyte Substitution Therapy |
33.3% |
| Hypertension |
33.3% |
|
|
